Faculty Opinions recommendation of Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19.

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)

The American Journal of Cardiology ◽

10.1016/j.amjcard.2021.02.009 ◽

2021 ◽

Vol 147 ◽

pp. 58-60

Author(s):

Hazrije Mustafic ◽

Abdallah Fayssoil ◽

Loïc Josseran ◽

Mounir Ouadahi ◽

Lamiae Grimaldi-Bensouda ◽

...

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients ◽

Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

Immunopharmacology and Immunotoxicology ◽

10.3109/08923973.2013.797992 ◽

2013 ◽

Vol 35 (3) ◽

pp. 447-450 ◽

Cited By ~ 10

Author(s):

Gino A. Vena ◽

Nicoletta Cassano ◽

Valeria Coco ◽

Clara De Simone

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Renin–angiotensin–aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?

Acta Diabetologica ◽

10.1007/s00592-005-0179-x ◽

2005 ◽

Vol 42 (S1) ◽

pp. s33-s41 ◽

Cited By ~ 10

Author(s):

L. M. Ruilope

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Renal Protection ◽

Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality

Hypertension ◽

10.1161/hypertensionaha.120.15622 ◽

2020 ◽

Vol 76 (2) ◽

Cited By ~ 14

Author(s):

Feng Zhou ◽

Ye-Mao Liu ◽

Jing Xie ◽

Haomiao Li ◽

Fang Lei ◽

...

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID‐19 infection in a multi‐site UK acute hospital trust

European Journal of Heart Failure ◽

10.1002/ejhf.1924 ◽

2020 ◽

Vol 22 (6) ◽

pp. 967-974 ◽

Cited By ~ 28

Author(s):

Daniel M. Bean ◽

Zeljko Kraljevic ◽

Thomas Searle ◽

Rebecca Bendayan ◽

O'Gallagher Kevin ◽

...

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Acute Hospital ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Re. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19

Epidemiology ◽

10.1097/ede.0000000000001250 ◽

2020 ◽

Vol Publish Ahead of Print ◽

Cited By ~ 1

Author(s):

Julie Rouette ◽

Karine Suissa ◽

Laurent Azoulay

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis

PLoS Computational Biology ◽

10.1371/journal.pcbi.1008235 ◽

2020 ◽

Vol 16 (10) ◽

pp. e1008235

Author(s):

Mehrshad Sadria ◽

Anita T. Layton

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Modeling Analysis ◽

Therapeutic trials comparing angiotensin converting enzyme inhibitors and Angiotensin II receptor blockers

Current Hypertension Reports ◽

10.1007/s11906-000-0045-8 ◽

2000 ◽

Vol 2 (4) ◽

pp. 402-411 ◽

Cited By ~ 36

Author(s):

William J. Elliott

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Therapeutic Trials ◽

Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers: Is There a Difference in Response and Any Advantage to Using Them Together in the Treatment of Hypertension?

Journal of Clinical Hypertension ◽

10.1111/j.1751-7176.2008.08560.x ◽

2008 ◽

Vol 10 (6) ◽

pp. 489-496 ◽

Cited By ~ 4

Author(s):

Marvin Moser ◽

Clive Rosendorff ◽

William B. White

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Treatment Of Hypertension ◽

Receipt of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers among Medicare beneficiaries with diabetes and hypertension

Journal of Pharmaceutical Health Services Research ◽

10.1111/jphs.12036 ◽

2013 ◽

Vol 5 (1) ◽

pp. 67-74 ◽

Cited By ~ 2

Author(s):

Junling Wang ◽

Satya Surbhi ◽

Julie W. Kuhle

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Medicare Beneficiaries ◽

Angiotensin Ii Receptor ◽